A prospective, multicenter study on the clinical effectiveness of abiraterone in metastatic castration-resistant prostate cancer in Korea: Pre- vs. post-chemotherapy

PURPOSE: The proper treatment sequence for administering abiraterone acetate plus prednisolone (AAP) and chemotherapeutic agents has not yet been elucidated for metastatic castration-resistant prostate cancer (mCRPC). Hence, this study evaluated the effectiveness and safety of AAP in pre- and post-c...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Seung-hwan, Yeon, Sang Eun, Kim, Su Youn, Kwon, Tae Gyun, Jeon, Seong Soo, Choi, Young Deuk, Kwon, Dongdeuk, Chung, Byung Ha, Hong, Sung-Hoo, Kim, Byung Hoon, Lee, Hyo Jin, Shin, Sang Joon, Choi, Woo Suk, Park, Sung Woo, Kang, Taek Won, Yun, Seok Joong, Cho, Jin Seon, Choi, See Min, Lee, Na-Ri, Kwak, Cheol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Urological Association 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10482671/
https://www.ncbi.nlm.nih.gov/pubmed/37668202
http://dx.doi.org/10.4111/icu.20230128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10482671/
https://www.ncbi.nlm.nih.gov/pubmed/37668202
http://dx.doi.org/10.4111/icu.20230128

Ejemplares similares